A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...
Gov. Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost of the ...
The OIG report points to gaps in documentation and decision-making transparency, particularly in the case of Aduhelm, where FDA records indicated only 13 meetings with Biogen, but congressional ...
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
AbbVie will commit less capital towards experimental medicines for psychiatric disease, CEO Robert Michael said at an ...
The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
The report found top pharmacy benefit managers made more than $7.3 billion by marking up the prices of dozens of generic ...